Active Portfolio

Supira

Participated in $35M Series B Financing in 2020

Exited Portfolio

ACIST

Sold to Bracco Group in 2001

ArteriA

Sold to W.L. Gore in 2005

Atritech

Sold to Boston Scientific (NYSE: BSX) in 2011

Boston Heart Diagnostics

Sold to Eurofins Scientific (Euronext: ERF) in 2015

CardiAQ Valve Technologies

Sold to Edwards LifeSciences (NYSE: EW) in 2015

Cardiologic

Sold to Boston Scientific (NYSE: BSX) in 2001

Claret Medical

Sold to Boston Scientific (NYSE: BSX) in 2018

CoreValve

Sold to Medtronic (NYSE: MDT) in 2009

Embolic Protection

Sold to Boston Scientific (NYSE: BSX) in 2001

Embrella Cardiovascular

Sold to Edwards LifeSciences (NYSE: EW) in 2011

Endologix

IPO (NASDAQ: ELGX) in 2000

Essential Medical

Sold to Teleflex (NYSE: TFX) in 2018

ImThera Medical

Sold to LivaNova (NASDAQ: LIVN) in 2018

Loma Vista Medical

Sold to C.R. Bard (NYSE: BCR) in 2013, now part of Becton Dickinson (NYSE: BDX)

Micrus Endovascular

IPO (NASDAQ: MEND) in 2005

Ovum Ventures

Sold to Medtronic (NYSE: MDT) in 2009

Rebound Therapeutics

Sold to Integra LifeSciences (NASDAQ: IART) in 2019

ReCor Medical

Sold to Otsuka Holdings (TYO: 4578) in 2018

Regis Medical

Exited in 2018

Vascular Science

Sold to St. Jude Medical (NYSE: STJ) in 1999, now part of Abbott Laboratories (NYSE: ABT)

Vascular Solutions

IPO (NASDAQ: VASC) in 2001, now part of Teleflex (NYSE: TFX)